HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Kosaku Nitta Selected Research

imidaprilat

2/2010MMP-9 inhibition by ACE inhibitor reduces oxidized LDL-mediated foam-cell formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Kosaku Nitta Research Topics

Disease

39Proteinuria
10/2015 - 05/2002
22Kidney Diseases (Kidney Disease)
12/2015 - 01/2008
20IGA Glomerulonephritis (IGA Nephropathy)
08/2015 - 05/2002
18Glomerulonephritis
07/2015 - 03/2003
15Cardiovascular Diseases (Cardiovascular Disease)
12/2015 - 12/2007
12Chronic Kidney Failure (Chronic Renal Failure)
01/2015 - 07/2002
11Hypertension (High Blood Pressure)
02/2013 - 01/2004
10Fibrosis (Cirrhosis)
12/2013 - 01/2003
10Nephrotic Syndrome (Syndrome, Nephrotic)
02/2013 - 01/2002
9Inflammation
04/2015 - 01/2002
7Infection
07/2015 - 01/2007
7Anemia
04/2015 - 08/2007
7Membranous Glomerulonephritis (Membranous Nephropathy)
01/2015 - 01/2002
6Sclerosis
12/2015 - 01/2003
6Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
03/2015 - 08/2009
6Diabetes Mellitus
02/2013 - 01/2008
6Hematuria
02/2013 - 01/2002
5Acute Kidney Injury (Acute Renal Failure)
07/2015 - 01/2005
5Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
07/2015 - 08/2004
5Albuminuria
01/2014 - 12/2010
5Diabetic Nephropathies (Diabetic Nephropathy)
02/2013 - 09/2004
5Hemorrhage
01/2010 - 01/2003
4Hyperuricemia
10/2015 - 07/2014
4Vasculitis (Vasculitides)
10/2013 - 08/2009
4Dyslipidemias (Dyslipidemia)
08/2012 - 01/2008
4Lupus Nephritis
04/2012 - 01/2009
4Arteriosclerosis
01/2009 - 08/2003
3Atherosclerosis
01/2015 - 02/2010
3Thrombosis (Thrombus)
05/2014 - 09/2002
3Body Weight (Weight, Body)
01/2014 - 03/2012
3Bone Diseases (Bone Disease)
04/2013 - 09/2009
3Nephritis
06/2011 - 01/2002
3Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
06/2011 - 07/2003
3Polycystic Kidney Diseases (Polycystic Kidney Disease)
12/2010 - 07/2009
3Thrombotic Thrombocytopenic Purpura
01/2010 - 01/2007
2Amyloidosis
12/2015 - 11/2010
2Hemolytic Anemia
07/2015 - 01/2007
2Hyperparathyroidism
01/2015 - 04/2011
2Sepsis (Septicemia)
01/2014 - 01/2005
2Peritoneal Fibrosis
05/2013 - 01/2003
2Neoplasms (Cancer)
05/2013 - 01/2011

Drug/Important Bio-Agent (IBA)

24CreatinineIBA
10/2015 - 05/2002
11Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
03/2015 - 01/2002
10Immunoglobulin A (IgA)IBA
10/2015 - 07/2003
8Immunoglobulin G (IgG)IBA
12/2015 - 06/2003
8Uric Acid (Urate)IBA
10/2015 - 01/2008
7rituximab (Mabthera)FDA Link
07/2015 - 01/2009
7Serum AlbuminIBA
01/2015 - 08/2007
6Immunoglobulins (Immunoglobulin)IBA
12/2015 - 07/2003
6C-Reactive ProteinIBA
10/2015 - 01/2007
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2015 - 12/2007
6Prednisolone (Predate)FDA LinkGeneric
01/2012 - 09/2002
5Parathyroid Hormone (Parathormone)IBA
01/2015 - 04/2011
5AdiponectinIBA
06/2013 - 01/2007
5Idiopathic minimal change nephrotic syndromeIBA
06/2011 - 12/2007
4Allopurinol (Remid)FDA LinkGeneric
10/2015 - 07/2014
4IronIBA
04/2015 - 01/2012
4Angiotensin Receptor AntagonistsIBA
01/2015 - 07/2009
4Biological Markers (Surrogate Marker)IBA
05/2013 - 01/2011
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2012 - 09/2002
3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2015 - 01/2002
3Tacrolimus (Prograf)FDA LinkGeneric
07/2015 - 01/2009
3FibrinIBA
02/2015 - 01/2003
3Eicosapentaenoic AcidIBA
01/2015 - 12/2010
3NitrogenIBA
01/2015 - 01/2007
3Urea (Carbamide)FDA LinkGeneric
01/2015 - 01/2007
3glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2014 - 11/2010
3Hemoglobins (Hemoglobin)IBA
01/2014 - 08/2007
3Glucose (Dextrose)FDA LinkGeneric
05/2013 - 01/2008
3cinacalcet (Sensipar)FDA Link
02/2013 - 02/2010
3HDL CholesterolIBA
10/2012 - 06/2012
3SteroidsIBA
04/2012 - 01/2002
3AngiotensinsIBA
10/2011 - 05/2010
3CholesterolIBA
01/2011 - 01/2007
3Immunoglobulin M (IgM)IBA
12/2010 - 07/2003
3thymidine 5'-triphosphate (TTP)IBA
01/2010 - 01/2007
3antiglomerular basement membrane antibodyIBA
12/2009 - 10/2004
3AntibodiesIBA
01/2009 - 09/2002
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2015 - 04/2012
2febuxostatFDA Link
10/2015 - 11/2014
2Lipoproteins (Lipoprotein)IBA
10/2015 - 08/2012
2HematinicsIBA
01/2015 - 02/2013
2ErythropoietinFDA Link
01/2014 - 01/2002
2DiureticsIBA
01/2014 - 07/2009
2CalciumIBA
10/2013 - 04/2013
2Insulin (Novolin)FDA Link
09/2013 - 01/2010
2PhosphorusIBA
04/2013 - 07/2005
2Angiotensin Receptors (Angiotensin II Receptor)IBA
02/2013 - 09/2008

Therapy/Procedure

41Renal Dialysis (Hemodialysis)
12/2015 - 01/2002
6Kidney Transplantation
07/2015 - 01/2005
6Transplants (Transplant)
07/2015 - 08/2004
6Transplantation (Transplant Recipients)
07/2015 - 01/2005
4Tonsillectomy
10/2015 - 01/2011
4Homologous Transplantation (Allograft)
07/2015 - 08/2004
4Plasma Exchange
07/2015 - 01/2007
4Aftercare (After-Treatment)
01/2013 - 01/2007
3Peritoneal Dialysis
05/2013 - 01/2003
3Highly Active Antiretroviral Therapy (HAART)
05/2013 - 10/2011
3Plasmapheresis
02/2008 - 09/2002
2Drug Therapy (Chemotherapy)
01/2014 - 01/2011